Waters acquires Megadalton Solutions,Inc. to broaden CDMS technology application

Waters Corporation (MA, USA) has announced its acquisition of the technology assets and intellectual property rights of Megadalton Solutions, Inc. (IN, USA), an early-stage developer of charge detection mass spectrometry (CDMS) technology and services Udit Batra, President and CEO of Waters Corporation, commented: “Large molecule mass spectrometry with CDMS offers an important tool for the characterization, analysis and quantification of next-generation biologics, such as cell and gene therapies, which is an area of high interest among biopharmaceutical and biomedical research customers.” You may also be interested in: KCAS to acquire FlowMetric, LLC to better serve cell and gene therapy programs...